poisar

Stocks · News reference

GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals

BenzingaJul 28, 2026, 5:30 PMVandana Singh

GSK beats Q2 revenue and earnings estimates, launches a $2.52B cost-savings program, and updates its 2026 guidance.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 28, 2026, 5:30 PM
Checked
Jul 28, 2026, 5:30 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading